Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2017 Update Clinical Practice Guideline
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2017 Update Clinical Practice Guideline
  • Published Date:

    March 2018

  • Status:
    current
  • Language:
    English
Filetype[PDF-1.67 MB]


Details:
  • Supporting Files:
    No Additional Files
    1. Filetype[PDF - 1.62 MB]
      Corporate Authors:
      United States. Public Health Service.. Centers for Disease Control and Prevention (U.S.). National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention. Preexposure Prophylaxis Work Group..
      Published Date:
      March 2018
      Description:
      The Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2014 Clinical Providers’ Supplement was published in an electronic format in July 2014 so that it could be updated as relevant changes in supporting evidence b...
      Status:
      current
      File Type:
      Filetype[PDF - 1.62 MB]
This document has replaced (most recent first):
  1. Filetype[PDF - 791.62 KB]
    Corporate Authors:
    United States. Public Health Service.. Centers for Disease Control and Prevention (U.S.). National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.).
    Published Date:
    05/07/2014
    Description:
    This publication provides a comprehensive clinical practice guideline for the use of PrEP for the prevention of HIV infection in the United States. It incorporates and extends information provided in interim guidance for PrEP use with MSM, with heter...
    Status:
    superseded
    File Type:
    Filetype[PDF - 791.62 KB]

You May Also Like:

  1. Filetype[PDF - 791.62 KB]
    Corporate Authors:
    United States. Public Health Service.. Centers for Disease Control and Prevention (U.S.). National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.).
    Published Date:
    05/07/2014
    Description:
    This publication provides a comprehensive clinical practice guideline for the use of PrEP for the prevention of HIV infection in the United States. It incorporates and extends information provided in interim guidance for PrEP use with MSM, with heter...
    Status:
    superseded
    File Type:
    Filetype[PDF - 791.62 KB]
  2. Filetype[PDF - 690.62 KB]
    Personal Author:
    Smith, Dawn K.; Koenig, Linda J.; Martin, Michael; Mansergh, Gordon; Heneine, Walid; Ethridge, Steven F.; Morgan, Marie S.; Mermin, Jonathan; Fenton, Kevin A.;
    Corporate Authors:
    United States. Public Health Service.. Centers for Disease Control and Prevention (U.S.). National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.).
    Published Date:
    May 14, 2014
    Description:
    For the Clinical Practice Guideline that serves as the basis for this Clinical Providers’ Supplement, see Preexposure prophylaxis for the prevention of HIV infection – 2014 : a clinical practice guideline. al Practice Guideline that serves as the...
    Status:
    superseded
    File Type:
    Filetype[PDF - 690.62 KB]
  3. Filetype[PDF - 1.47 MB]
    Personal Author:
    Heneine, Walid; Thompson, Melanie; Smith, Dawn K.; Iskander, John K.; Thorpe, Phoebe; Laird, Susan;
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Communication.. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention
..
    Published Date:
    May 20, 2014
    Source:
    Public health grand rounds ; 2014 April 22
    Description:
    An estimated 50,000 individuals become infected with the human immunodeficiency virus (HIV) in the United States annually. A new prevention strategy, Pre-exposure Prophylaxis (PrEP), is intended for high-risk populations to reduce their risk of becom...
    File Type:
    Filetype[PDF - 1.47 MB]
  4. Filetype[PDF - 615.54 KB]
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Centers for Disease Control and Prevention (U.S.).
    Published Date:
    February 2011
    Source:
    CDC fact sheet
    Description:
    New tools to prevent HIV are urgently needed to stem the estimated 2.6 million new HIV infections that occur worldwide each year. Recent research has shown that a new approach called pre-exposure prophylaxis, or PrEP, can reduce the risk of contracti...
    File Type:
    Filetype[PDF - 615.54 KB]
  5. Filetype[PDF - 137.96 KB]
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (U.S.). Division of HIV/AIDS Prevention. Act Against Aids.
    Published Date:
    1/12/17
    Series:
    Act Against AIDS
    Start Talking. Stop HIV.
    Description:
    This little pill is changing the HIV consversation.PrEP (Pre-Exposure Prophylaxis) is an HIV prevention pill. When taken daily, it can greatly reduce your risk of getting HIV.There are more HIV prevention options than ever before. Talk to your doctor...
    File Type:
    Filetype[PDF - 137.96 KB]